This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
fin-tech: Archive
Can JPMorgan's IB Business Momentum Continue Into 2026?
by Swayta Shah
JPMorgan's IB momentum stays strong with double-digit fee growth and a robust deal pipeline heading into 2026.
fin-tech finance
PYPL Shares Rise on Q3 Earnings Beat, 2025 EPS Guidance Raised
by Zacks Equity Research
PayPal's Q3 results reflect a year-over-year rise in revenues, TPV and transaction margin dollars. However, a fall in payment transactions remains a concern.
earnings fin-tech
EastGroup Properties (EGP)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
STNE vs. UPST: Which Fintech Stock Should You Pick Now?
by Moumita C. Chattopadhyay
StoneCo's steady profitability and disciplined growth outshine Upstart's volatile AI-driven lending surge, making it the stronger fintech contender now.
artificial-intelligence fin-tech
After a Solid Q3, is JPMorgan Stock a Buy at Current Levels?
by Swayta Shah
JPM's robust Q3 results, rising NII and strong capital markets gains fuel optimism despite its premium valuation. Let's find out whether the stock is a buy.
banking fin-tech finance
New Strong Buy Stocks for Oct. 28: NCNO, VRT, and More
by Zacks Equity Research
NCNO, VRT, BFH, MEDP and MCFT have been added to the Zacks Rank #1 (Strong Buy) List on October 28, 2025.
computers consumer-discretionary fin-tech medical
OPFI vs. SOFI: Which Fintech Credit Stock Is the Better Buy Right Now?
by Arghyadeep Bose
OppFi's niche subprime strategy and rising earnings contrast with SoFi Technologies' scale-driven growth and expanding profitability. Let us determine which fintech stock looks stronger now.
artificial-intelligence business-services fin-tech finance
How Should You Play OppFi Stock Ahead of Q3 Earnings Release?
by Arghyadeep Bose
As OPFI readies third-quarter 2025 results, investors eye its AI-powered lending gains, lower charge-offs and strong liquidity footing.
artificial-intelligence business-services fin-tech
SOFI Technologies to Report Q3 Earnings: Here's What to Expect
by Zacks Equity Research
SOFI is set to report Q3 results, with revenue and earnings expected to show strong double-digit growth.
earnings fin-tech finance
SoFi Technologies Stock Before Q3 Earnings: To Buy or Not to Buy?
by Shuvra Shankar Dey
SOFI's Q3 results could impress again, but its surging stock and rich valuation test investor conviction.
earnings-preview fin-tech finance